缺氧(环境)
肿瘤缺氧
肿瘤微环境
医学
前药
药品
转移
提拉帕扎明
药物输送
临床试验
癌症研究
生物信息学
药理学
放射治疗
癌症
病理
肿瘤细胞
生物
内科学
化学
氧气
体外
有机化学
细胞毒性
生物化学
作者
Mohammad Shahpouri,Mohammad Amin Adili-Aghdam,Hossein Mahmudi,Mehdi Jaymand,Zohreh Amoozgar,Mohsen Akbari,Michael R. Hamblin,Rana Jahanban‐Esfahlan
标识
DOI:10.1016/j.jconrel.2022.12.009
摘要
Hypoxia is a unique characteristic of the solid tumor microenvironment. Hypoxia contributes to multi-drug resistance, metastasis and cancer relapse through numerous molecular pathways, but at the same time provides an opportunity for the development of novel drugs or modalities specifically targeting hypoxic tumor regions. Given the high significance of tumor hypoxia in therapeutic results, we here discuss a variety of hypoxia-adopted strategies, and their potential and utility in the treatment of deep-seated hypoxic tumor cells. We discuss the merits and demerits of these approaches, as well as their combination with other approaches such as photodynamic therapy. We also survey the currently available 3D hypoxia modeling systems, in particular organoid-based microfluidics. Finally, we discuss the potential and the current status of preclinical tumor hypoxia approaches in clinical trials for advanced cancer. We believe that multi-modal imaging and therapeutic hypoxia adopted drug delivery platforms could provide better efficacy and safety profiles, and more importantly personalized therapy. Determining the hypoxia status of tumors could offer a second chance for the clinical translation of hypoxia-based agents, such as hypoxia activated prodrugs (HAPs) from bench to bedside.
科研通智能强力驱动
Strongly Powered by AbleSci AI